Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis

BACKGROUND: Chronic kidney disease-associated pruritus (CKD-aP) is associated with an increased risk of depression, poor sleep and reduced health-related quality of life. Two phase III studies (KALM-1 and KALM-2) of difelikefalin showed reduced CKD-aP severity and improved itch-related health-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Thokala, Praveen, Hnynn Si, Pann Ei, Hernandez Alava, Monica, Sasso, Alessandro, Schaufler, Thilo, Soro, Marco, Fotheringham, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020261/
https://www.ncbi.nlm.nih.gov/pubmed/36735201
http://dx.doi.org/10.1007/s40273-022-01237-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020261/
https://www.ncbi.nlm.nih.gov/pubmed/36735201
http://dx.doi.org/10.1007/s40273-022-01237-4

Ejemplares similares